These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25543014)

  • 1. HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients.
    Mossallam GI; Fattah RA; El-Haddad A; Mahmoud HK
    Hum Immunol; 2015 Mar; 76(2-3):161-5. PubMed ID: 25543014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Jalali A; Ghasemzadeh M
    Leuk Res; 2013 May; 37(5):516-9. PubMed ID: 23395341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
    Tamouza R; Busson M; Rocha V; Fortier C; Haddad Y; Brun M; Boukouaci W; Bleux H; Socié G; Krishnamoorthy R; Toubert A; Gluckman E; Charron D
    Transplantation; 2006 Dec; 82(11):1436-40. PubMed ID: 17164714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
    Verheyden S; Schots R; Duquet W; Demanet C
    Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic polymorphism and allogeneic hematopoietic transplantation outcome.
    Mullighan CG; Petersdorf EW
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):19-27. PubMed ID: 16399580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
    Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
    Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-E polymorphisms in hematopoietic stem cell transplantation.
    Fürst D; Bindja J; Arnold R; Herr W; Schwerdtfeger R; Müller CH; Recker K; Schrezenmeier H; Mytilineos J
    Tissue Antigens; 2012 Apr; 79(4):287-90. PubMed ID: 22256791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
    Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
    Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.
    Nakamura R; La Rosa C; Tsai W; Lacey SF; Srivastava T; Seidel A; Senitzer D; Forman SJ; Diamond DJ
    Transpl Immunol; 2014 May; 30(4):128-35. PubMed ID: 24582729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
    Ciurea SO; Saliba RM; Rondon G; Patah PA; Aung F; Cano P; Andersson BS; Kebriaei P; Popat U; Fernandez-Vina M; Champlin RE; de Lima M
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):923-9. PubMed ID: 20969970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors.
    Rådestad E; Wikell H; Engström M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
    J Immunol Res; 2014; 2014():578741. PubMed ID: 25371909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.